Energy source comparison in en-bloc resection of bladder tumors: subanalysis of a single-center prospective randomized study.

Diagnosis Endoscopy Energies Energy Resection Treatment Urothelial cancer

Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 24 02 2022
accepted: 02 05 2022
medline: 23 10 2023
pubmed: 1 6 2022
entrez: 31 5 2022
Statut: ppublish

Résumé

Different energy sources are employed to perform en-bloc transurethral resection of bladder tumor (ERBT). No study compared different energy sources in ERBT. The aim is to compare the different ERBT sources in terms of pathological, surgical and postoperative outcomes. This is a sub-analysis of a prospective randomized trial enrolling patients submitted to ERBT vs conventional TURBT from 03/2018 to 06/2021 (NCT04712201). 180 patients enrolled in ERBT group were randomized 1:1:1 to receive monopolar (m-ERBT), bipolar (b-ERBT) or thulium laser (l-ERBT). Endpoints were the comparison between energies in term of pathological analysis, intra, and post-operative outcomes. 49 (35%) m-ERBT, 45 (32.1%) b-ERBT, and 46 (32.9%) l-ERBT were included in final analysis. The rate of detrusor muscle (DM) presence was comparable between the energies used (p = 0.796) or the location of the lesion (p = 0.662). Five (10.2%), 10 (22.2%) and 0 cases of obturator nerve reflex (ONR) were recorded in m-ERBT, b-ERBT and I-ERBT groups, respectively (p = 0.001). Conversion to conventional TURBT was higher for lesions located in the anterior wall/dome/neck (p < 0.001), irrespective from the energy used. The presence of artifact in the pathological specimen was higher for lesions at the posterior wall (p = 0.03) and trigone (p = 0.03). In our study, no difference in staging feasibility among energies was found. Laser energy might be beneficial in lateral wall lesions to avoid ONR. Since there is an increased risk of ERBT conversion to conventional TURBT for lesions of the anterior wall, electrocautery might be preferred over laser to avoid waste of material.

Identifiants

pubmed: 35639159
doi: 10.1007/s00345-022-04042-y
pii: 10.1007/s00345-022-04042-y
pmc: PMC9152642
doi:

Substances chimiques

Thulium 8RKC5ATI4P

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2591-2597

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Babjuk M, Burger M, Capoun O et al (2022) European association of urology guidelines on non–muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ). Eur Urol 81(1):75–94. https://doi.org/10.1016/j.eururo.2021.08.010
doi: 10.1016/j.eururo.2021.08.010 pubmed: 34511303
Mariappan P, Zachou A, Grigor KM (2010) Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol. https://doi.org/10.1016/j.eururo.2009.05.047
doi: 10.1016/j.eururo.2009.05.047 pubmed: 19524354
Dalbagni G, Herr HW, Reuter VE (2002) Impact of a second transurethral resection on the staging of T1 bladder cancer. Urology 60(5):822–824. https://doi.org/10.1016/S0090-4295(02)01920-9
doi: 10.1016/S0090-4295(02)01920-9 pubmed: 12429307
Kawada T, Ebihara K, Suzuki T, Imai K, Yamanaka H (1997) A new technique for transurethral resection of bladder tumors: rotational tumor resection using a new arched electrode. J Urol 157(6):2225–2226. https://doi.org/10.1016/S0022-5347(01)64724-4
doi: 10.1016/S0022-5347(01)64724-4 pubmed: 9146621
Teoh JYC, MacLennan S, Chan VWS et al (2020) An international collaborative consensus statement on en bloc resection of bladder tumour incorporating two systematic reviews, a two-round delphi survey, and a consensus meeting. Eur Urol 78(4):546–569. https://doi.org/10.1016/j.eururo.2020.04.059
doi: 10.1016/j.eururo.2020.04.059 pubmed: 32389447
Territo A, Bevilacqua G, Meneghetti I, Mercadé A, Breda A (2020) En bloc resection of bladder tumors: indications, techniques, and future directions. Curr Opin Urol. https://doi.org/10.1097/MOU.0000000000000737
doi: 10.1097/MOU.0000000000000737 pubmed: 32205806
Kramer MW, Altieri V, Hurle R et al (2017) Current evidence of transurethral En-bloc resection of nonmuscle invasive bladder cancer. Eur Urol Focus. https://doi.org/10.1016/j.euf.2016.12.004
doi: 10.1016/j.euf.2016.12.004 pubmed: 28753835
TNM classification of malignant (2018) Tumours. 8th edn
Orsola A, Trias I, Raventós CX et al (2005) Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients. Eur Urol 48(2):231–238. https://doi.org/10.1016/j.eururo.2005.04.013
doi: 10.1016/j.eururo.2005.04.013 pubmed: 15963635
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. https://doi.org/10.1097/01.sla.0000133083.54934.ae
doi: 10.1097/01.sla.0000133083.54934.ae pubmed: 15570203 pmcid: 1356513
Sylvester RJ, Rodríguez O, Hernández V et al (2021) European association of urology (EAU) prognostic factor risk groups for non–muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC guidelines panel [formula present]. Eur Urol 79(4):480–488. https://doi.org/10.1016/j.eururo.2020.12.033
doi: 10.1016/j.eururo.2020.12.033 pubmed: 33419683
Sari Motlagh R, Rajwa P, Mori K et al (2021) Comparison of Clinicopathologic and oncological outcomes between transurethral en bloc resection and conventional transurethral resection of bladder tumor: a systematic review, meta-analysis and network meta-analysis with focus on different energy sources. J Endourol. https://doi.org/10.1089/end.2021.0688
doi: 10.1089/end.2021.0688 pubmed: 34693740
Teoh JYC, MacLennan S, Chan VWS et al (2020) An international collaborative consensus statement on en bloc resection of bladder tumour incorporating two systematic reviews, a two-round delphi survey, and a consensus meeting. Eur Urol. https://doi.org/10.1016/j.eururo.2020.04.059
doi: 10.1016/j.eururo.2020.04.059 pubmed: 32972792 pmcid: 7347487
Hashem A, Mosbah A, El-Tabey NA et al (2020) Holmium laser En-bloc resection versus conventional transurethral resection of bladder tumors for treatment of non–muscle-invasive bladder cancer: a randomized clinical trial. Eur Urol Focus 2020:1–9. https://doi.org/10.1016/j.euf.2020.12.003
doi: 10.1016/j.euf.2020.12.003
Liu H, Wu J, Xue S et al (2013) Comparison of the safety and efficacy of conventional monopolar and 2-micron laser transurethral resection in the management of multiple nonmuscle-invasive bladder cancer. J Int Med Res 41(4):984–992. https://doi.org/10.1177/0300060513477001
doi: 10.1177/0300060513477001 pubmed: 23760914
Zhang XR, Feng C, Zhu WD et al (2015) Two micrometer continuous-wave thulium laser treating primary non-muscle-invasive bladder cancer: is it feasible? A randomized prospective study. Photomed Laser Surg 33(10):517–523. https://doi.org/10.1089/pho.2015.3913
doi: 10.1089/pho.2015.3913 pubmed: 26397029
Bangash M, Ather MH, Khan N, Mohammad S, Uddin Z (2020) Comparison of recurrence rate between “EN BLOC” resection of bladder tumour and conventional technique for non-muscle invasive bladder cancer. J Ayub Med Coll Abbottabad 32(4):435–440
pubmed: 33225639
Yang Y, Liu C, Yang X, Wang D (2020) Transurethral en bloc resection with monopolar current for non-muscle invasive bladder cancer based on TNM system. Transl Cancer Res 9(4):2210–2219. https://doi.org/10.21037/tcr.2020.03.48
doi: 10.21037/tcr.2020.03.48 pubmed: 35117581 pmcid: 8798135
Bălan GX, Geavlete PA, Georgescu DA et al (2018) Bipolar en bloc tumor resection versus standard monopolar TURBT—which is the best way to go in non-invasive bladder cancer? Rom J Morphol Embryol 59(3):773–780
pubmed: 30534816
Poletajew S, Krajewski W, Stelmach P et al (2021) En-bloc resection of urinary bladder tumour—a prospective controlled multicentre observational study. Wideochirurgia I Inne Tech Maloinwazyjne 16(1):145–150. https://doi.org/10.5114/WIITM.2020.95399
doi: 10.5114/WIITM.2020.95399
Miyake M, Nishimura N, Fujii T et al (2021) Photodynamic diagnosis-assisted en bloc transurethral resection of bladder tumor for nonmuscle invasive bladder cancer: short-term oncologic and functional outcomes. J Endourol 35(3):319–327. https://doi.org/10.1089/end.2020.0371
doi: 10.1089/end.2020.0371 pubmed: 32940054
Deniz B, Bulent G, Tansu D et al (2016) Comparing the short-term outcomes and complications of monopolar and bipolar transurethral resection of non-muscle invasive bladder cancers: a prospective, randomized, controlled study. Arch Esp Urol 69(5):225–233. https://doi.org/10.1016/s1569-9056(16)15040-7
doi: 10.1016/s1569-9056(16)15040-7
Venkatramani V, Panda A, Manojkumar R KN. (2014) Monopolar versus bipolar transurethral resection of bladder tumors: a single center, parallel arm, randomized, controlled trial. J Urol 191(6):1703–1707. http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L53105161%5Cnhttp://dx.doi.org/ https://doi.org/10.1016/j.juro.2013.12.004
Kramer MW, Rassweiler JJ, Klein J et al (2015) En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol. https://doi.org/10.1007/s00345-015-1568-6
doi: 10.1007/s00345-015-1568-6 pubmed: 26267808

Auteurs

Pietro Diana (P)

Fundació Puigvert, Department of Urology, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain. pietros.diana@gmail.com.
Department of Urology, Humanitas Research Hospital-IRCCS, Rozzano, Italy. pietros.diana@gmail.com.

Andrea Gallioli (A)

Fundació Puigvert, Department of Urology, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Matteo Fontana (M)

Fundació Puigvert, Department of Urology, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Angelo Territo (A)

Fundació Puigvert, Department of Urology, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Alejandra Bravo (A)

Fundació Puigvert, Department of Urology, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Alberto Piana (A)

Fundació Puigvert, Department of Urology, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Michael Baboudjian (M)

Fundació Puigvert, Department of Urology, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.
Department of Urology, APHM, North Academic Hospital, Marseille, France.
Department of Urology, La Croix du Sud Hôpital, Quint Fonsegrives, France.

Pavel Gavrilov (P)

Fundació Puigvert, Department of Urology, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Óscar Rodriguez-Faba (Ó)

Fundació Puigvert, Department of Urology, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Josep Maria Gaya (JM)

Fundació Puigvert, Department of Urology, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Ferran Algaba (F)

Fundació Puigvert, Department of Pathology, Autonomous University of Barcelona, Barcelona, Spain.

Joan Palou (J)

Fundació Puigvert, Department of Urology, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Alberto Breda (A)

Fundació Puigvert, Department of Urology, Autonomous University of Barcelona, Cartagena 340-350, 08025, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH